We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$5.93B
AUM Growth
+$411M
Cap. Flow
+$220M
Cap. Flow %
3.71%
Top 10 Hldgs %
18.58%
Holding
2,656
New
107
Increased
1,107
Reduced
377
Closed
19

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.76M
2
AMZN icon
Amazon
AMZN
+$7.95M
3
DOW icon
Dow Inc
DOW
+$5.98M
4
META icon
Meta Platforms (Facebook)
META
+$4.77M
5
AAPL icon
Apple
AAPL
+$4.04M

Sector Composition

Rank Sector Weight
1 Technology 17.56%
2 Financials 14.09%
3 Healthcare 12.58%
4 Industrials 10.29%
5 Consumer Discretionary 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTS icon
1751
Virtus Investment Partners
VRTS
$1.14B
$248K ﹤0.01%
2,313
CNR
1752
Core Natural Resources Inc
CNR
$4.64B
$248K ﹤0.01%
9,332
LILA icon
1753
Liberty Latin America Class A
LILA
$1.67B
$248K ﹤0.01%
22,494
ANGO icon
1754
AngioDynamics
ANGO
$647M
$247K ﹤0.01%
12,559
TCDA
1755
DELISTED
Tricida, Inc. Common Stock
TCDA
$247K ﹤0.01%
6,263
+317
+5% +$11.1K
PARR icon
1756
Par Pacific Holdings
PARR
$4.12B
$247K ﹤0.01%
12,038
MAGN
1757
Magnera Corp
MAGN
$433M
$247K ﹤0.01%
1,124
+41
+4% +$8.17K
VYGR icon
1758
Voyager Therapeutics
VYGR
$198M
$246K ﹤0.01%
9,048
MDGL icon
1759
Madrigal Pharmaceuticals
MDGL
$11.7B
$246K ﹤0.01%
2,349
+87
+4% +$9.32K
ASIX icon
1760
AdvanSix
ASIX
$446M
$246K ﹤0.01%
10,066
ADVM
1761
DELISTED
Adverum Biotechnologies
ADVM
$246K ﹤0.01%
2,065
TVRD
1762
Tvardi Therapeutics
TVRD
$22.1M
$245K ﹤0.01%
316
CASS icon
1763
Cass Information Systems
CASS
$750M
$244K ﹤0.01%
5,038
LION
1764
DELISTED
Fidelity Southern Corporation
LION
$244K ﹤0.01%
7,876
MOD icon
1765
Modine Manufacturing
MOD
$10.8B
$243K ﹤0.01%
17,014
+1,066
+7% +$15.2K
FOCS
1766
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$243K ﹤0.01%
8,888
+516
+6% +$16.8K
VNDA icon
1767
Vanda Pharmaceuticals
VNDA
$304M
$242K ﹤0.01%
17,187
CERS icon
1768
Cerus
CERS
$572M
$242K ﹤0.01%
43,028
UBA
1769
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$242K ﹤0.01%
11,507
-12
-0.1% -$260
CISN
1770
DELISTED
Cision Ltd. Ordinary Share
CISN
$242K ﹤0.01%
20,594
TDW icon
1771
Tidewater
TDW
$4.55B
$241K ﹤0.01%
10,253
+567
+6% +$13K
AUD
1772
DELISTED
Audacy, Inc.
AUD
$240K ﹤0.01%
41,372
GTT
1773
DELISTED
GTT Communications, Inc.
GTT
$239K ﹤0.01%
13,587
MHO icon
1774
M/I Homes
MHO
$3.9B
$239K ﹤0.01%
8,378
EXTR icon
1775
Extreme Networks
EXTR
$3.16B
$239K ﹤0.01%
36,946
+2,509
+7% +$16.6K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2019 Portfolio in Review

As of Q2 2019, Metropolitan Life Insurance Company (MetLife) held 2,656 positions worth $5.93B, up 7.5% from $5.52B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Metropolitan Life Insurance Company (MetLife) deployed $220M of net new capital in Q2 2019, opening 107 new positions and adding to 1,107 existing holdings. Its largest new stake was Dow Inc: 113,293 shares worth $5.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $9.22M trimmed.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2019 buy was Dow Inc: 113,293 shares worth $5.59M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q2 2019, an estimated $9.76M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $9.22M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Integrated Device Technology I in Q2 2019, selling an estimated $3.61M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 19% of its $5.93B portfolio in Q2 2019.
  • Metropolitan Life Insurance Company (MetLife) opened 107 new positions and closed 19 in Q2 2019.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 7.5% quarter-over-quarter to $5.93B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2019, filed 14 Aug 2019.